Biogen Upgrade, Regeneron Downgrade and Roblox Initiations: Top Calls on Wall Street

202
7
Favorite

Biogen Upgrade, Regeneron Downgrade and Roblox Initiations: Top Calls on Wall Street

The Fly2022-10-26

Top 5 Upgrades:Goldman Sachs analyst Salveen Richter upgraded Biogen (BIIB) to Buy from Neutral with a price target of $370, up from $220, after updating his 2022 sales estimates for quarterly trends ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

202

Report

Comment（7）

Simonnov
·2022-10-27
Ic
Reply
Like
Report
YJ Lee
·2022-10-27
K
Reply
Like
Report
Seah CL
·2022-10-27
K
Reply
2
Report
Seah CL
·2022-10-27
K
Reply
Like
Report
RK888
·2022-10-27
👍
Reply
1
Report
Fold Replies
- qstocks:
  k
  2022-10-27
  Reply
  Report
- RK888:
  👍
  2022-10-27
  Reply
  Report
phantom74
·2022-10-27
oike
Reply
3
Report
Ghostwalker
·2022-10-27
Good
Reply
1
Report
Fold Replies
- Kelvinphan:
  Ye
  2022-10-27
  Reply
  Report

Most Discussed

7x24

All

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/1120821590?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2022-10-26 23:25","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1120821590","market":"us","top_or_hot":-1,"title":"Biogen Upgrade, Regeneron Downgrade and Roblox Initiations: Top Calls on Wall Street","media":"The Fly","content":"<div>\n<p>Top 5 Upgrades:Goldman Sachs analyst Salveen Richter upgraded Biogen (BIIB) to Buy from Neutral with a price target of $370, up from $220, after updating his 2022 sales estimates for quarterly trends ...</p>\n\n<a href=\"https://thefly.com/landingPageNews.php?id=3602984&headline=BIIB;HUM;DFS;BHVN;PFE;CGC;REGN;ALLY;WHR;CCK;BKR;RBLX;ABT;TFX;EW;SHFS;CHRA-Street-Wrap-Todays-Top--Upgrades-Downgrades-Initiations\">Source Link</a>\n\n</div>\n","source":"lsy1649979459173","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Biogen Upgrade, Regeneron Downgrade and Roblox Initiations: Top Calls on Wall Street</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBiogen Upgrade, Regeneron Downgrade and Roblox Initiations: Top Calls on Wall Street\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-10-26 23:25 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://thefly.com/landingPageNews.php?id=3602984&headline=BIIB;HUM;DFS;BHVN;PFE;CGC;REGN;ALLY;WHR;CCK;BKR;RBLX;ABT;TFX;EW;SHFS;CHRA-Street-Wrap-Todays-Top--Upgrades-Downgrades-Initiations><strong>The Fly</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Top 5 Upgrades:Goldman Sachs analyst Salveen Richter upgraded Biogen (BIIB) to Buy from Neutral with a price target of $370, up from $220, after updating his 2022 sales estimates for quarterly trends ...</p>\n\n<a href=\"https://thefly.com/landingPageNews.php?id=3602984&headline=BIIB;HUM;DFS;BHVN;PFE;CGC;REGN;ALLY;WHR;CCK;BKR;RBLX;ABT;TFX;EW;SHFS;CHRA-Street-Wrap-Todays-Top--Upgrades-Downgrades-Initiations\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BKR","symbol_name":"贝克休斯","start_time":0,"source_url":"https://thefly.com/landingPageNews.php?id=3602984&headline=BIIB;HUM;DFS;BHVN;PFE;CGC;REGN;ALLY;WHR;CCK;BKR;RBLX;ABT;TFX;EW;SHFS;CHRA-Street-Wrap-Todays-Top--Upgrades-Downgrades-Initiations","article_id":"1120821590","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1120821590","pubTimestamp":1666797931,"columns":[],"sourceInfo":{"source_id":"lsy1649979459173","name":"The Fly"},"weMediaInfo":null,"summary":"Top 5 Upgrades:Goldman Sachs analyst Salveen Richter upgraded Biogen (BIIB) to Buy from Neutral with","collect":0,"end_time":0,"defaultTopTitle":"thefly.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BKR":"贝克休斯","DFS":"发现金融","BHVN":"Biohaven Pharmaceutical Holding Co Ltd.","GOVX":"GeoVax Labs Inc","ABT":"雅培","RBLX":"Roblox Corporation","CGC":"Canopy Growth Corporation","REGN":"再生元制药公司","WHR":"惠而浦","HUM":"哈门那","ALLY":"Ally Financial Inc.","CCK":"皇冠控股","BIIB":"渤健公司"},"translate_title":"Biogen升级、Regeneron降级和Roblox启动：华尔街的热门电话","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ABT":0.9,"ALLY":0.9,"BHVN":0.9,"BIIB":0.9,"BKR":0.9,"CCK":0.9,"CGC":0.9,"CHRA":0.9,"DFS":0.9,"GOVX":0.9,"HUM":0.9,"RBLX":0.9,"REGN":0.9,"WHR":0.9},"content_text":"Top 5 Upgrades:Goldman Sachs analyst Salveen Richter upgraded Biogen (BIIB) to Buy from Neutral with a price target of $370, up from $220, after updating his 2022 sales estimates for quarterly trends and revised guidance and increasing his lecanemab sales forecasts based on the recent positive Phase 3 topline dataDeutsche Bank analyst George Hill upgraded Humana (HUM) to Buy from Hold with a price target of $576, up from $514. The analyst says six regional independent Medicare Advantage brokers confirmed to him the solidifying of Humana's leading position in Medicare Advantage, and the rising challenges facing many of its competitors.Morgan Stanley analyst Betsy Graseck upgraded Discover Financial Services (DFS) to Overweight from Equal Weight with a price target of $116, up from $104, citing the resumption of the share buyback.Cantor Fitzgerald analyst Charles Duncan upgraded Biohaven Pharmaceutical (BHVN) to Overweight from Neutral with a price target of $27, down from $158, following the completion of the sale of its anti-CGRP assets to Pfizer (PFE) for $148.50 per share in cash, which was preceded by the spinout of its remaining assets into a SpinCo.Canaccord analyst Matt Bottomley upgraded Canopy Growth (CGC) to Hold from Sell with a price target of C$4.25, up from C$2.75, following the company's series of announcements to streamline and create a holding company, Canopy USA, to consolidate its U.S. THC operations.Top 5 Downgrades:Raymond James analyst Dane Leone downgraded Regeneron Pharmaceuticals (REGN) to Underperform from Market Perform without a price target. In a research note to investors, Leone says that the life cycle extension benefit of 8mg aflibercept is likely over-estimated and that the oncology portfolio is likely to continue to struggle during 2023.Compass Point analyst Giuliano Bologna downgraded Ally Financial (ALLY) to Neutral from Buy with a price target of $27, down from $50, following the company’s third quarter earnings miss and issuance of a \"significantly weaker\" updated outlook for earnings through fiscal 2023.BofA analyst Elizabeth Suzuki downgraded Whirlpool (WHR) to Underperform from Neutral with a price target of $119, down from $155. Industry and company data suggest a severe drop in appliance demand and softening of pricing, Suzuki told investors.JPMorgan analyst Jeffrey Zekauskas downgraded Crown Holdings (CCK) to Neutral from Overweight with a price target of $71, down from $115. It will be difficult for Crown to capture an enhanced trading multiple with little free cash flow generation likely for 2022 or 2023, Zekauskas argued.Wells Fargo analyst Roger Read downgraded Baker Hughes (BKR) to Equal Weight from Overweight with a price target of $29, down from $32. The analyst sees Baker as a \"show me\" stock \"that could easily continue to lag its peers for another quarter or two.\"Top 5 Initiations:DA Davidson analyst Franco Granda initiated coverage of Roblox (RBLX) with a Buy rating and $55 price target. The analyst is positive on the company's \"user-first platform approach,\" its ability to outperform Mobile Gaming peers with a fraction of cost, the emerging opportunities to improve economics at a platform-wide level, and a growing number of use cases beyond gaming. Piper Sandler analyst Thomas Champion also initiated coverage of Roblox with an Overweight rating and $54 price target.Mizuho analyst Anthony Petrone initiated coverage of Abbott Laboratories (ABT) with a Neutral rating and $105 price target. The analyst says the Neutral rating balances the benefits of the company's \"solid\" positioning in several of the fastest growing medical technology markets and \"fortress\" balance sheet against COVID testing and infant formula recall/relaunch headwinds. He also started Teleflex (TFX) with a Neutral and Edwards Lifesciences (EW) with a Buy rating.H.C. Wainwright analyst Vernon Bernardino initiated coverage of GeoVax Labs (GOVX) with a Buy rating and $8 price target. GeoVax's pipeline \"shows promise as up-and-coming vaccines for infectious diseases and cancer,\" Bernardino told investors in a research note.EF Hutton analyst Michael Albanese initiated coverage ofSHF Holdings(SHFS) with a Buy rating and $10.50 price target. The company's Safe Harbor Financial provides compliant access to banking and financial services for customers in the cannabis industry, which is growing and \"starved for capital,\" Albanese said.BofA analyst Sherif El-Sabbahy reinstated coverage of Charah Solutions (CHRA) with an Underperform rating and $1.65 price target. While Charah has \"undergone substantial changes in the past two years\" by divesting its \"sizable\" nuclear power plant services business unit, refocusing around core coal ash markets, introducing new products to its coal ash services portfolio and refreshing management with a new CFO, Charah \"continues to be plagued by high leverage, low FCF, and unprofitable legacy projects\" and remains a \"show me\" story given its challenges, the analyst told investors.","kind":"news","is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":9988449667,"gmtCreate":1666826885659,"gmtModify":1676537811081,"author":{"id":"4097750438225520","authorId":"4097750438225520","name":"Simonnov","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"4097750438225520","authorIdStr":"4097750438225520"},"htmlText":"Ic","listText":"Ic","text":"Ic","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9988449667","repostId":1120821590,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9988450865,"gmtCreate":1666826000457,"gmtModify":1676537810776,"author":{"id":"4108816210230400","authorId":"4108816210230400","name":"YJ Lee","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"4108816210230400","authorIdStr":"4108816210230400"},"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9988450865","repostId":1120821590,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9988462545,"gmtCreate":1666824524587,"gmtModify":1676537810359,"author":{"id":"4102135564535180","authorId":"4102135564535180","name":"Seah CL","avatar":"https://community-static.tradeup.com/news/970bca7b04e85a42a2c8eabed7ec96d0","vip":1,"crmLevel":3,"crmLevelSwitch":0,"idStr":"4102135564535180","authorIdStr":"4102135564535180"},"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9988462545","repostId":1120821590,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9988462266,"gmtCreate":1666824518455,"gmtModify":1676537810358,"author":{"id":"4102135564535180","authorId":"4102135564535180","name":"Seah CL","avatar":"https://community-static.tradeup.com/news/970bca7b04e85a42a2c8eabed7ec96d0","vip":1,"crmLevel":3,"crmLevelSwitch":0,"idStr":"4102135564535180","authorIdStr":"4102135564535180"},"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9988462266","repostId":1120821590,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9988483046,"gmtCreate":1666822883585,"gmtModify":1676537809960,"author":{"id":"3584063721837527","authorId":"3584063721837527","name":"RK888","avatar":"https://static.tigerbbs.com/c94493ec39af6df82d06fcfa8afb3483","vip":1,"crmLevel":5,"crmLevelSwitch":0,"idStr":"3584063721837527","authorIdStr":"3584063721837527"},"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/9988483046","repostId":1120821590,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":104524740,"gmtCreate":1666824779785,"gmtModify":1666824779785,"authorId":3581746780935690,"author":{"id":3581746780935690,"idStr":"3581746780935690","authorId":3581746780935690,"name":"qstocks","avatar":"https://static.tigerbbs.com/cd471dd6c55721dad90e1c808f35bdd8","vip":1,"currentWearingBadge":{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.01.13","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1001},"crmLevel":2,"crmLevelSwitch":1,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9988483046,"type":1,"supId":0,"prevId":0,"content":"<span class=\"s1\">k</span>","text":"<span class=\"s1\">k</span>","html":"<span class=\"s1\">k</span>"},{"id":104524282,"gmtCreate":1666822892595,"gmtModify":1666822892595,"authorId":3584063721837527,"author":{"id":3584063721837527,"idStr":"3584063721837527","authorId":3584063721837527,"name":"RK888","avatar":"https://static.tigerbbs.com/c94493ec39af6df82d06fcfa8afb3483","vip":1,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9988483046,"type":1,"supId":0,"prevId":0,"content":"<span class=\"s1\">👍</span>","text":"<span class=\"s1\">👍</span>","html":"<span class=\"s1\">👍</span>"}],"langContent":"EN"},{"id":9988413676,"gmtCreate":1666821665095,"gmtModify":1676537809547,"author":{"id":"3570342809089528","authorId":"3570342809089528","name":"phantom74","avatar":"https://static.tigerbbs.com/c87ef2af41b8696be86cceafb5b5723d","vip":1,"hat":"https://static.tigerbbs.com/b0a2963eb37c60c5d6d4a8dbcd266952","crmLevel":3,"crmLevelSwitch":0,"idStr":"3570342809089528","authorIdStr":"3570342809089528"},"htmlText":"oike","listText":"oike","text":"oike","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9988413676","repostId":1120821590,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9988437944,"gmtCreate":1666820925488,"gmtModify":1676537809454,"author":{"id":"4095988560725080","authorId":"4095988560725080","name":"Ghostwalker","avatar":"https://static.tigerbbs.com/23573df57053ba2bfe809c087c7ce4b1","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"4095988560725080","authorIdStr":"4095988560725080"},"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/9988437944","repostId":1120821590,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":104524373,"gmtCreate":1666823392169,"gmtModify":1666823392169,"authorId":3579053062900901,"author":{"id":3579053062900901,"idStr":"3579053062900901","authorId":3579053062900901,"name":"Kelvinphan","avatar":"https://static.tigerbbs.com/dd87884547b7d5f0157a229e9ea4e890","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9988437944,"type":1,"supId":0,"prevId":0,"content":"<span class=\"s1\">Ye</span>","text":"<span class=\"s1\">Ye</span>","html":"<span class=\"s1\">Ye</span>"}],"langContent":"EN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":202,"commentSize":7,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}